You can buy or sell CTI BioPharma and other stocks, options, ETFs, and crypto commission-free!
CTI BioPharma Corp. (DE) Common Stock, also called CTI BioPharma, is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. Read More It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.
52 Week High
52 Week Low
— per share
Expected Jul 30, After Hours